{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T13:14:59Z","timestamp":1777814099867,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R15AI138847"],"award-info":[{"award-number":["1R15AI138847"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.antiviral.2019.104598","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T19:05:00Z","timestamp":1568055900000},"page":"104598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Cellular Signaling Analysis shows antiviral, ribavirin-mediated ribosomal signaling modulation"],"prefix":"10.1016","volume":"171","author":[{"given":"Xianting","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter O.","family":"Krutzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Ali","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixiu","family":"Zhaozhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Daniel","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genhong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Ming","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garry P.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Jesse","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.antiviral.2019.104598_bib1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"Al-Lazikani","year":"2012","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.antiviral.2019.104598_bib2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007161","article-title":"HIV-1 antiretroviral drug therapy","volume":"2","author":"Arts","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6030","key":"10.1016\/j.antiviral.2019.104598_bib3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.1198704","article-title":"Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum","volume":"332","author":"Bendall","year":"2011","journal-title":"Science"},{"issue":"153","key":"10.1016\/j.antiviral.2019.104598_bib4","doi-asserted-by":"crossref","first-page":"rs4","DOI":"10.1126\/scisignal.2001182","article-title":"Phosphoproteomic analysis reveals interconnected system-wide responses to perturbations of kinases and phosphatases in yeast","volume":"3","author":"Bodenmiller","year":"2010","journal-title":"Sci. Signal."},{"issue":"9","key":"10.1016\/j.antiviral.2019.104598_bib5","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nbt.2317","article-title":"Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators","volume":"30","author":"Bodenmiller","year":"2012","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.104598_bib6","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1038\/s41598-017-10198-0","article-title":"Determining Ribavirin's mechanism of action against Lassa virus infection","volume":"7","author":"Carrillo-Bustamante","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.antiviral.2019.104598_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3947\/ic.2015.47.3.212","article-title":"Antiviral treatment guidelines for Middle East respiratory Syndrome","volume":"47","author":"Chong","year":"2015","journal-title":"Infect Chemother"},{"issue":"3","key":"10.1016\/j.antiviral.2019.104598_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/cyto.b.21207","article-title":"Flow cytometric analysis of intracellular phosphoproteins in human monocytes","volume":"92","author":"Coppin","year":"2017","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"10.1016\/j.antiviral.2019.104598_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00109-001-0308-0","article-title":"Ribavirin's antiviral mechanism of action: lethal mutagenesis?","volume":"80","author":"Crotty","year":"2002","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.antiviral.2019.104598_bib10","first-page":"2281","article-title":"Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity","volume":"7","author":"Ding","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.antiviral.2019.104598_bib11","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/11\/6\/065003","article-title":"Discovery of a low order drug-cell response surface for applications in personalized medicine","volume":"11","author":"Ding","year":"2014","journal-title":"Phys. Biol."},{"issue":"9","key":"10.1016\/j.antiviral.2019.104598_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137917","article-title":"Phosphoflow-based evaluation of mek inhibitors as small-molecule therapeutics for B-cell precursor acute lymphoblastic leukemia","volume":"10","author":"George","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104598_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-4939-6527-4_17","article-title":"Phospho-flow analysis of primary mouse cells after HDAC inhibitor treatment","volume":"1510","author":"Hildebrand","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.antiviral.2019.104598_bib14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/jvi.70.1.647-650.1996","article-title":"The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein","volume":"70","author":"Horvath","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104598_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.coviro.2014.06.003","article-title":"Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance","volume":"8","author":"James","year":"2014","journal-title":"Curr Opin Virol"},{"issue":"1","key":"10.1016\/j.antiviral.2019.104598_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1128\/CMR.00043-15","article-title":"Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding","volume":"29","author":"Johnston","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2019.104598_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.08.007","article-title":"Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice","volume":"146","author":"Kamiyama","year":"2017","journal-title":"Antivir. Res."},{"issue":"5","key":"10.1016\/j.antiviral.2019.104598_bib18","first-page":"316","article-title":"Hepatitis C in a new era: a review of current therapies","volume":"42","author":"Kish","year":"2017","journal-title":"PT"},{"issue":"5899","key":"10.1016\/j.antiviral.2019.104598_bib19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.1164164","article-title":"Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency","volume":"322","author":"Knickelbein","year":"2008","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.antiviral.2019.104598_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth872","article-title":"Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling","volume":"3","author":"Krutzik","year":"2006","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.antiviral.2019.104598_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nchembio.2007.59","article-title":"High-content single-cell drug screening with phosphospecific flow cytometry","volume":"4","author":"Krutzik","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.antiviral.2019.104598_bib22","doi-asserted-by":"crossref","first-page":"14183","DOI":"10.1038\/ncomms14183","article-title":"Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time","volume":"8","author":"Lee","year":"2017","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.antiviral.2019.104598_bib23","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1073\/pnas.1114981109","article-title":"Systematic identification of type I and type II interferon-induced antiviral factors","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.antiviral.2019.104598_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1386-6532(02)00263-9","article-title":"Herpes simplex virus resistance to antiviral drugs","volume":"26","author":"Morfin","year":"2003","journal-title":"J. Clin. Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2019.104598_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nprot.2016.017","article-title":"Optimization of drug combinations using feedback system control","volume":"11","author":"Nowak-Sliwinska","year":"2016","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.antiviral.2019.104598_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","article-title":"Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management","volume":"55","author":"Piret","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.antiviral.2019.104598_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.tibs.2006.04.003","article-title":"Ribosomal protein S6 phosphorylation: from protein synthesis to cell size","volume":"31","author":"Ruvinsky","year":"2006","journal-title":"Trends Biochem. Sci."},{"issue":"5721","key":"10.1016\/j.antiviral.2019.104598_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1126\/science.1105809","article-title":"Causal protein-signaling networks derived from multiparameter single-cell data","volume":"308","author":"Sachs","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104598_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IDR.S96164","article-title":"Optimal management of genital herpes: current perspectives","volume":"9","author":"Sauerbrei","year":"2016","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.antiviral.2019.104598_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4137\/CGM.S11134","article-title":"Enhancing cancer drug discovery through novel cell signaling pathway panel strategy","volume":"6","author":"Schweizer","year":"2013","journal-title":"Cancer Growth Metastasis"},{"key":"10.1016\/j.antiviral.2019.104598_bib31","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1600812113","article-title":"Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model","author":"Silva","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"205","key":"10.1016\/j.antiviral.2019.104598_bib32","doi-asserted-by":"crossref","first-page":"205rv1","DOI":"10.1126\/scitranslmed.3006667","article-title":"High-throughput methods for combinatorial drug discovery","volume":"5","author":"Sun","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.antiviral.2019.104598_bib33","first-page":"218","article-title":"Mechanism of action of ribavirin in the treatment of chronic hepatitis C","volume":"3","author":"Te","year":"2007","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.antiviral.2019.104598_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fcimb.2019.00127","article-title":"Herpes simplex virus evasion of early host antiviral responses","volume":"9","author":"Tognarelli","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.antiviral.2019.104598_bib35","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1038\/srep14508","article-title":"A streamlined search technology for identification of synergistic drug combinations","volume":"5","author":"Weiss","year":"2015","journal-title":"Sci. Rep."},{"issue":"9267","key":"10.1016\/j.antiviral.2019.104598_bib36","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","article-title":"Herpes simplex virus infections","volume":"357","author":"Whitley","year":"2001","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.antiviral.2019.104598_bib37","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1073\/pnas.0800823105","article-title":"Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm","volume":"105","author":"Wong","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219300221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219300221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:11:37Z","timestamp":1777497097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219300221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":37,"alternative-id":["S0166354219300221"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104598","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular Signaling Analysis shows antiviral, ribavirin-mediated ribosomal signaling modulation","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104598"}}